Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-38
Closed -$7.97K 1460
2026
Q1
$7.97K Buy
+38
New +$9.55K ﹤0.01% 1009
2025
Q1
Sell
-6
Closed -$1.57K 998
2024
Q4
$1.57K Hold
6
﹤0.01% 869
2024
Q3
$1.4K Hold
6
﹤0.01% 873
2024
Q2
$1.21K Hold
6
﹤0.01% 889
2024
Q1
$1.03K Hold
6
﹤0.01% 881
2023
Q4
$1.3K Buy
+6
New +$1.03K ﹤0.01% 813
2017
Q4
Sell
-2,222
Closed -$122K 511
2017
Q3
$122K Hold
2,222
0.02% 153
2017
Q2
$114K Hold
2,222
0.02% 152
2017
Q1
$96K Hold
2,222
0.02% 171
2016
Q4
$84K Hold
2,222
0.02% 162
2016
Q3
$91K Hold
2,222
0.02% 148
2016
Q2
$67K Hold
2,222
0.02% 191
2016
Q1
$74K Buy
+2,222
New +$69.8K 0.02% 157

Other funds holding PODD

MCF Advisors's PODD Position: Q2 2026 in Review

MCF Advisors sold out of Insulet (PODD) in Q2 2026, closing a stake of 38 shares — an estimated $7.97K sold.

MCF Advisors first reported a position in PODD in Q1 2016 and held it in 13 quarters. The position peaked at $122K in Q3 2017. 726 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • MCF Advisors reported no remaining Insulet position as of Q2 2026 after selling out during the quarter.
  • MCF Advisors sold 38 Insulet shares in Q2 2026, an estimated $7.97K.
  • MCF Advisors first reported a position in Insulet in Q1 2016 and held it in 13 quarters.
  • MCF Advisors's Insulet position peaked at $122K in Q3 2017.
  • 726 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on MCF Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.